EchoSolv AS vs FibriCheck
AI Verdict
Choose EchoSolv AS if…
Choose EchoSolv AS if your cardiology department needs an AI-powered clinical decision support tool to efficiently and accurately identify patients at high risk for severe aortic stenosis from existing echocardiogram measurements. This platform is ideal for streamlining the review process, providing second reader support, and prioritizing studies for closer clinical examination within your existing PACS workflow.
View EchoSolv AS →Choose FibriCheck if…
Choose FibriCheck if you are a patient seeking a convenient, smartphone-based solution for regular remote heart rhythm monitoring to detect arrhythmias like Atrial Fibrillation. Healthcare providers should consider FibriCheck to offer their patients an accessible tool for continuous cardiac rhythm oversight, enabling early detection and management of abnormalities outside the clinic.
View FibriCheck →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | EchoSolv AS | FibriCheck |
|---|---|---|
| Pricing | Unknown | Subscription-based, with options for monthly or annual payments. prices vary by region and may be partly or fully covered by insurance or employer. |
| Deployment | Cloud-based | Cloud-based (private cloud). |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
FibriCheckWhile EchoSolv AS focuses on seamless integration into existing clinical workflows for healthcare professionals, FibriCheck offers a highly user-friendly experience for both patients and providers. Multiple studies highlight FibriCheck's ease of use and high patient satisfaction, leveraging ubiquitous smartphone technology for remote monitoring.
Clinical Value
TieBoth tools offer significant clinical value, are FDA-cleared, and are backed by extensive clinical validation. EchoSolv AS provides highly accurate decision support for a critical and often underdiagnosed condition (severe aortic stenosis), directly aiding clinicians in diagnosis and prioritization. FibriCheck offers robust and accurate remote monitoring for various arrhythmias, empowering patients and enabling earlier detection and management of conditions like AFib. Their value propositions address different, yet equally important, aspects of cardiac care.
Pricing & Value
FibriCheckFibriCheck offers transparent and detailed pricing for both end-users and healthcare providers, including subscription models and per-measurement fees. Tool A, while indicating a subscription-based model and potential reimbursement rates, does not provide explicit pricing details for its service to hospitals or clinics. FibriCheck's clear pricing structure allows for a better assessment of its value proposition.
Enterprise Readiness
EchoSolv ASBoth tools demonstrate strong enterprise readiness with FDA clearance, HIPAA compliance, and cloud deployment. However, EchoSolv AS explicitly states BAA, integrates seamlessly with PACS without EMR integration, and adheres to multiple data standards (FHIR, HL7 v2, DICOM). Its deployment in large hospital systems like Mount Sinai further solidifies its enterprise capabilities for clinical workflow integration.
Innovation
EchoSolv ASWhile FibriCheck innovates by making cardiac monitoring accessible via smartphones, EchoSolv AS demonstrates a more specialized and technically innovative approach. Its 'measurement-based AI' that 'does not use LVOT measurements' for severe aortic stenosis diagnosis addresses a specific clinical hurdle with a unique methodology, leading to improved accuracy and reduced diagnostic bias in a critical area of cardiology.
Support & Docs
FibriCheckFibriCheck clearly outlines a robust support system, including a detailed online Help Center with user manuals for both patients and professionals, FAQs, and dedicated sections for different user types. It also provides direct contact for support and integration queries. While EchoSolv AS mentions supporting documentation for reimbursement, FibriCheck's publicly available and comprehensive support resources are more extensive and transparent.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | EchoSolv AS | FibriCheck |
|---|---|---|
| Name | EchoSolv AS | FibriCheck |
| Company | Echo IQ | Qompium nv |
| Description | FDA-cleared, AI-powered clinical decision support platform that analyzes echocardiograms to identify patients at risk for severe aortic stenosis with high accuracy and efficiency, integrating into existing workflows. | Medically certified app that helps patients monitor their heart rhythm to detect and monitor arrhythmias using just their smartphone. |
| Primary Function | Identify high-probability severe aortic stenosis (sAS) patients | Detect and monitor arrhythmias |
| Key Technology | Measurement-based AI (analyzes numerical measurements, not images) | Smartphone camera-based PPG technology for heart rhythm measurement |
| Target User | Healthcare professionals (Cardiology, Cardiothoracic Surgery) | Patients (with healthcare professional portal/dashboard) |
Videos
Demos, reviews, and walkthroughs featuring EchoSolv AS and FibriCheck.